CN104013747A - Traditional Chinese medicine oral liquid for treating lumbar disc herniation - Google Patents
Traditional Chinese medicine oral liquid for treating lumbar disc herniation Download PDFInfo
- Publication number
- CN104013747A CN104013747A CN201410278900.2A CN201410278900A CN104013747A CN 104013747 A CN104013747 A CN 104013747A CN 201410278900 A CN201410278900 A CN 201410278900A CN 104013747 A CN104013747 A CN 104013747A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- oral liquid
- medicine oral
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine oral liquid for treating lumbar disc herniation. The traditional Chinese medicine oral liquid for treating lumbar disc herniation is prepared from the following raw medicines by weight: 120g of astragalus membranaceus, 30g of angelica sinensis, 30g of rehmannia glutinosa, 18g of as arum, 45g of cassia twig, 45g of radix paeoniae alba, 30g of radices sileris, 30g of semen cuscutae, 30g of fructus psoraleae, 30g of herba epimedii, 20g of eucommia ulmoides, 18g of caulis spatholobi, 15g of poria, 15g of rhizoma alismatis and 15g of rhizoma atractylodis. The traditional Chinese medicine oral liquid for treating lumbar disc herniation is capable of reinforcing kidney to replenish essence, invigorating the circulation of blood to remove stasis, activating meridians to stop pain, optimally stimulating nidus, dredging the channel, removing stagnation of qi and blood, facilitating the circulation of blood, achieving the effect of strengthening body resistance and eliminating evil and achieving excellent clinical curative effect.
Description
Technical field
The present invention relates to Chinese medicine, be specifically related to a kind of Chinese medicine oral liquid for the treatment of prolapse of lumbar intervertebral disc.
Background technology
At present, prolapse of lumbar intervertebral disc is a frequently-occurring disease, commonly encountered diseases, and it is mainly deviate from etc. because of lumbar intervertebral disc strain degeneration, Anular disruption or vertebral pulp, stimulates or series of symptoms group that compressing spinal nerves, spinal cord etc. cause.Oral western medicine or Chinese medicine that general treatment adopts, easily produce certain side effect to health, and the therapeutic effect of some medicine for external use is not satisfactory.
Summary of the invention
Technical problem to be solved by this invention is to provide the Chinese medicine oral liquid of a kind for the treatment of both the principal and secondary aspects of a disease, drug effect is rapid, safe and reliable, therapeutic effect is good treatment prolapse of lumbar intervertebral disc.
For solving the problems of the technologies described above, the Chinese medicine oral liquid for the treatment of prolapse of lumbar intervertebral disc of the present invention is to be made by following bulk drugs: 120 grams of the Radixs Astragali, 30 grams of Radix Angelicae Sinensis, 30 grams, Radix Rehmanniae Preparata, 18 grams of Herba Asaris, 45 grams of Ramulus Cinnamomi, 45 grams of the Radix Paeoniae Albas, 30 grams of Radix Saposhnikoviaes, 30 grams of Semen Cuscutae, 30 grams of Fructus Psoraleaes, 30 grams of Herba Epimedii, 20 grams of the Cortexs Eucommiae, 18 grams of Caulis Spatholobis, 15 grams of Poria, 15 grams of Rhizoma Alismatis, 15 grams of Rhizoma Atractylodis.
The preparation method for the treatment of the Chinese medicine oral liquid of prolapse of lumbar intervertebral disc is: get every crude drug, decoct with water 45 ~ 60 minutes, filter to obtain decocting liquid, then decoct with water 45 ~ 60 minutes in medicinal residues, filter to obtain decocting liquid; Merge the decocting liquid of twice, being concentrated into relative density is 1.1 ~ 1.3, obtains.
Medicine of the present invention is to select the Radix Astragali, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, Herba Asari, Ramulus Cinnamomi, the Radix Paeoniae Alba, Radix Saposhnikoviae, Semen Cuscutae, Fructus Psoraleae, Herba Epimedii, the Cortex Eucommiae, Caulis Spatholobi, Poria, Rhizoma Alismatis, Rhizoma Atractylodis combine preparation, make each efficacy of drugs produce synergism these drug regimens, thereby can effectively treat prolapse of lumbar intervertebral disc.The Radix Astragali (invigorating QI to consolidate the body surface resistance wherein, diuretic), Radix Angelicae Sinensis (is enriched blood, invigorate blood circulation), Radix Rehmanniae Preparata (the yin nourishing of enriching blood, life essence-filling, marrow-benefitting), (Herba Asari induces sweat cold expelling, wind-expelling pain-stopping, sensible, warming the lung to resolve fluid-retention), Ramulus Cinnamomi (complement sun, promoting blood circulation, warming the spleen and stomach), the Radix Paeoniae Alba (blood-supplementing blood-nourishing, suppressing liver-YANG, easing the affected liver to relieve pain), Radix Saposhnikoviae (expelling pathogenic wind from the body surface, removing dampness to relieve pain, spasmolytic, antipruritic), Semen Cuscutae (the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity), Fructus Psoraleae (impotence due to deficiency of the kidney, soreness of the waist and knees cold type of pain), Herba Epimedii (kidney invigorating and YANG supporting, expelling wind and removing dampness), the Cortex Eucommiae (invigorating the liver and kidney, strong waist knee joint, bone and muscle strengthening), Caulis Spatholobi (relaxing muscles and tendons to promote blood circulation, nourishing blood for regulating menstruation), Poria (edema distension), Rhizoma Alismatis (dysuria, edema distension), Rhizoma Atractylodis are (drying damp and strengthening spleen, wind-damp dispelling).
The cure rate 69% of Chinese medicine oral liquid treatment prolapse of lumbar intervertebral disc of the present invention, obvious effective rate 10%,, effective percentage 8%, average total effective rate 87%.There is determined curative effect, the feature that easy to use, toxic and side effects is little.
The specific embodiment
By 120 grams of the Radixs Astragali, 30 grams of Radix Angelicae Sinensis, 30 grams, Radix Rehmanniae Preparata, 18 grams of Herba Asaris, 45 grams of Ramulus Cinnamomi, 45 grams of the Radix Paeoniae Albas, 30 grams of Radix Saposhnikoviaes, 30 grams of Semen Cuscutae, 30 grams of Fructus Psoraleaes, 30 grams of Herba Epimedii, 20 grams of the Cortexs Eucommiae, 18 grams of Caulis Spatholobis, 15 grams of Poria, 15 grams of Rhizoma Alismatis, 15 grams of Rhizoma Atractylodis are put into water and are decocted 45 ~ 60 minutes, filter to obtain decocting liquid, then decoct with water 45 ~ 60 minutes in medicinal residues, filter to obtain decocting liquid; Merge the decocting liquid of twice, being concentrated into relative density is 1.1 ~ 1.3, obtains oral liquid of the present invention.
The usage of oral liquid of the present invention: every day 2 times, each serving using 30ml.It within 45 days, is a course for the treatment of.
The criterion of therapeutical effect of oral liquid of the present invention adopts national Chinese medicine industry standard, specific as follows:
1, recovery from illness: waist, skelalgia transference cure, Ipsilateral straight-leg raising test, 75 ° more than-80 °, nonfunctional obstacle;
2, effective: waist, skelalgia symptom disappear substantially, Ipsilateral straight-leg raising test, 50 °-75 °, without manifest function obstacle;
3, effective: waist, skelalgia symptom make moderate progress, straight-leg raising test, 45 °-60 °;
4, invalid: lumbago and skelalgia symptom is as before treating.
Oral liquid cure rate 69% of the present invention, obvious effective rate 10%,, effective percentage 8%, average total effective rate 87%.Effective percentage is shown in curative effect table.
Claims (2)
1. a Chinese medicine oral liquid for the treatment of prolapse of lumbar intervertebral disc, is characterized in that: be to be made by following bulk drugs: 120 grams of the Radixs Astragali, 30 grams of Radix Angelicae Sinensis, 30 grams, Radix Rehmanniae Preparata, 18 grams of Herba Asaris, 45 grams of Ramulus Cinnamomi, 45 grams of the Radix Paeoniae Albas, 30 grams of Radix Saposhnikoviaes, 30 grams of Semen Cuscutae, 30 grams of Fructus Psoraleaes, 30 grams of Herba Epimedii, 20 grams of the Cortexs Eucommiae, 18 grams of Caulis Spatholobis, 15 grams of Poria, 15 grams of Rhizoma Alismatis, 15 grams of Rhizoma Atractylodis.
2. a kind of preparation method for the treatment of the Chinese medicine oral liquid of prolapse of lumbar intervertebral disc claimed in claim 1, is characterized in that: get every crude drug, decoct with water 45 ~ 60 minutes, filter to obtain decocting liquid, then decoct with water 45 ~ 60 minutes in medicinal residues, filter to obtain decocting liquid; Merge the decocting liquid of twice, being concentrated into relative density is 1.1 ~ 1.3, obtains.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410278900.2A CN104013747A (en) | 2014-06-21 | 2014-06-21 | Traditional Chinese medicine oral liquid for treating lumbar disc herniation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410278900.2A CN104013747A (en) | 2014-06-21 | 2014-06-21 | Traditional Chinese medicine oral liquid for treating lumbar disc herniation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104013747A true CN104013747A (en) | 2014-09-03 |
Family
ID=51430930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410278900.2A Pending CN104013747A (en) | 2014-06-21 | 2014-06-21 | Traditional Chinese medicine oral liquid for treating lumbar disc herniation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104013747A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106474397A (en) * | 2015-11-28 | 2017-03-08 | 衡阳春天医药化工设备有限公司 | A kind of Chinese medicine for treating lumbar spine pain and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102038930A (en) * | 2010-09-19 | 2011-05-04 | 左霖 | Medicament for treating protrusion of lumbar vertebral disc |
| CN102258754A (en) * | 2010-05-27 | 2011-11-30 | 杨晓杰 | Medicine for treating protrusion of lumbar vertebral disc |
-
2014
- 2014-06-21 CN CN201410278900.2A patent/CN104013747A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102258754A (en) * | 2010-05-27 | 2011-11-30 | 杨晓杰 | Medicine for treating protrusion of lumbar vertebral disc |
| CN102038930A (en) * | 2010-09-19 | 2011-05-04 | 左霖 | Medicament for treating protrusion of lumbar vertebral disc |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106474397A (en) * | 2015-11-28 | 2017-03-08 | 衡阳春天医药化工设备有限公司 | A kind of Chinese medicine for treating lumbar spine pain and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512565B (en) | Traditional Chinese medicine composition for treating lumbago due to kidney deficiency | |
| CN103007216B (en) | Chinese medicinal composition for treating chronic diarrhea | |
| CN100361704C (en) | Medicated wine for treating rheumatosis and osteoarthropathy | |
| CN103585299B (en) | Medicine for treating disc protrusion and bulge of lumbar vertebra and cervical vertebra | |
| CN103191383A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN103536777B (en) | Traditional Chinese medicinal composition for treating knee osteoarthritis | |
| CN103933200A (en) | Traditional Chinese medicine composition for treating apoplexy sequela | |
| CN101690768B (en) | Vein and artery relieving pills for impediment of sinew | |
| CN103893380A (en) | Traditional Chinese medicinal preparation for treating vertebral hyperosteogeny | |
| CN104906333A (en) | Traditional Chinese medicine composition for enhancing cardio-pulmonary function | |
| CN104013769A (en) | Traditional Chinese medicine oral solution for treating osteoporosis | |
| CN102247458A (en) | Capsule for warming collaterals and relaxing tendons | |
| CN104000933A (en) | Traditional Chinese medicine oral liquid for treating osteoproliferation | |
| CN103721082B (en) | A kind of Chinese medicine composition of cure scapulohumeral periarthritis | |
| CN102283929A (en) | Chinese medicinal composition for treating talalgia | |
| CN102988943B (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN104888111A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation | |
| CN104013939A (en) | Traditional Chinese medicine oral solution for treating scapulohumeral periarthritis | |
| CN104784614A (en) | Traditional Chinese medicine composition for treating kidney deficiency | |
| CN104771489A (en) | Traditional Chinese medicine composition for treating rheumatoid arthritis | |
| CN103800840A (en) | Oral traditional Chinese medicine solution for treating cervical spondylosis | |
| CN104306848A (en) | Traditional Chinese medicinal composition for treating frequent micturition caused by deficiency of kidney | |
| CN104013747A (en) | Traditional Chinese medicine oral liquid for treating lumbar disc herniation | |
| CN102370688A (en) | Compound Chinese medicinal preparation for treating hyperosteogeny and preparation method thereof | |
| CN102512543B (en) | Chinese medicinal composition for treating rheumatoid arthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140903 |
|
| WD01 | Invention patent application deemed withdrawn after publication |